Schedule 13G ownership disclosure

TELIX PHARMACEUTICALS LTD

Ordinary Shares · CUSIP: 87961M105

Event date: 2024-11-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Behrenbruch Christian

    Shares: 23,329,006 · Class: 6.97%

  • Elk River Holdings Pty Ltd

    Shares: 22,675,000 · Class: 6.78%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-25-004496
Form type
SCHEDULE 13G
Filer
Behrenbruch Christian
CIK
CIK 2037713
Filed
Feb 14, 2025
Reporting period
Nov 12, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub